For decades, a liver tumor diagnosis often meant facing major surgery, radiation, or chemotherapy — treatments that could leave patients exhausted and facing long recoveries. Now, a groundbreaking technology is offering a gentler path forward.
The Edison Histotripsy System uses precisely focused sound waves to destroy liver tumors without any incisions, needles, or radiation. Hospitals across the country are rapidly adopting this approach, bringing new hope to patients closer to home.
Histotripsy is a non-invasive procedure that uses high-intensity, image-guided ultrasound pulses to mechanically break down and liquefy targeted tissue. Unlike traditional treatments that rely on heat, cold, or radiation, histotripsy works through a purely mechanical process.
The technology creates tiny “bubble clouds” inside the tumor. These bubbles rapidly expand and collapse, breaking the tumor cells apart at a microscopic level while leaving surrounding healthy tissue largely untouched.
The Edison system combines advanced ultrasound imaging with a robotic treatment head. Doctors can see the tumor in real time, precisely target it, and monitor the treatment as it happens.
The entire process is performed from outside the body. Most patients receive the treatment under general anesthesia, and many go home the same day or the next. Because there are no cuts or needles involved, the risk of infection and bleeding is significantly lower than with traditional surgery.
In a significant step forward for patients in the region, Marshall Health Network at Cabell Huntington Hospital became the first hospital in West Virginia to offer histotripsy. The network joined a growing list of leading health systems — including Renown Health in Nevada and Lehigh Valley Health Network in Pennsylvania — that have brought this technology to their communities.
These deployments mark an important expansion phase for the Edison Histotripsy System, moving it from major academic centers into more regional health networks. This means patients no longer have to travel hundreds of miles for this advanced option.
Histotripsy offers several meaningful advantages:
Clinical studies have shown high technical success rates in destroying targeted liver tumors, both primary liver cancers and tumors that have spread from other parts of the body.
Histotripsy is currently FDA-cleared for the non-invasive destruction of liver tumors. It is especially promising for patients who:
Not every patient is a candidate. Eligibility depends on tumor size, location, and overall health. A multidisciplinary team of specialists evaluates each case.
The rapid adoption of the Edison system by hospitals like Marshall Health Network signals growing confidence in histotripsy. Ongoing clinical trials are exploring its use in other organs, including the kidney and pancreas.
As more regional health systems bring this technology online, patients across the country will have greater access to a treatment that prioritizes both effectiveness and quality of life.
Histotripsy represents a genuine shift in how we approach liver tumors. By harnessing the power of sound waves, doctors can now destroy cancer mechanically — without the physical toll of traditional surgery or radiation.
For patients and families facing a liver tumor diagnosis, this technology offers something that was rarely available before: a precise, non-invasive option that may allow them to spend less time recovering and more time living.
If you or a loved one has been diagnosed with liver tumors, speak with your doctor about whether histotripsy could be an option. As more hospitals adopt the Edison system, this once-experimental approach is becoming an increasingly accessible reality.
Sources